| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Atlas Venture Opportunity Fund Ii, L.P. is a 10% Owner at Dyne Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $37.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2024 | KRRO Korro Bio, Inc. | 10% Owner | Buy | 17,857 | $56.00 | $999,992.00 | +10.1% | -29.2% | -76.1% | |
| Dec 12, 2022 | DYN Dyne Therapeutics, Inc. | 10% Owner | Buy | 934,581 | $10.70 | $10,000,016.70 | New | +13.1% | -5.9% | |
| Jun 17, 2022 | DAWN Day One Biopharmaceuticals, Inc. | 10% Owner | Buy | 766,667 | $15.00 | $11,500,005.00 | New | +44.3% | -16.1% |